Physician profile
Darius Peikari
NPI 1275590077
$331.21
in general payments reported to CMS, 2019-2025
7 companies · $272 in 2025
The $272 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $28.90 · 2024: $30.13 · 2025: $272.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $302.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $302.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $142.19 | 2025 | Freestyle Libre 3 |
| Kowa Pharmaceuticals America, INC. | $59.10 | 2025 | Zoryve |
| Novo Nordisk INC | $40.33 | 2024-2025 | Ozempic, Rybelsus |
| Exact Sciences Corporation | $29.14 | 2025 | Cologuard Collection Kit |
| Grt US Holding, INC. | $28.90 | 2022 | |
| Lilly USA, LLC | $16.23 | 2025 | Zepbound, Mounjaro |
| Glaxosmithkline, LLC. | $15.32 | 2024 | Trelegy Ellipta, Arexvy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Darius Peikari listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.